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A BS TR AC T
BACKGROUND
The role of bracing in patients with adolescent idiopathic scoliosis who are at risk for 
curve progression and eventual surgery is controversial.
METHODS
We conducted a multicenter study that included patients with typical indications for 
bracing due to their age, skeletal immaturity, and degree of scoliosis. Both a ran-
domized cohort and a preference cohort were enrolled. Of 242 patients included in 
the analysis, 116 were randomly assigned to bracing or observation, and 126 chose 
between bracing and observation. Patients in the bracing group were instructed to 
wear the brace at least 18 hours per day. The primary outcomes were curve progres-
sion to 50 degrees or more (treatment failure) and skeletal maturity without this de-
gree of curve progression (treatment success).
RESULTS
The trial was stopped early owing to the efficacy of bracing. In an analysis that in-
cluded both the randomized and preference cohorts, the rate of treatment success 
was 72% after bracing, as compared with 48% after observation (propensity-score–
adjusted odds ratio for treatment success, 1.93; 95% confidence interval [CI], 1.08 to 
3.46). In the intention-to-treat analysis, the rate of treatment success was 75% among 
patients randomly assigned to bracing, as compared with 42% among those ran-
domly assigned to observation (odds ratio, 4.11; 95% CI, 1.85 to 9.16). There was a 
significant positive association between hours of brace wear and rate of treatment 
success (P<0.001).
CONCLUSIONS
Bracing significantly decreased the progression of high-risk curves to the threshold 
for surgery in patients with adolescent idiopathic scoliosis. The benefit increased 
with longer hours of brace wear. (Funded by the National Institute of Arthritis and 
Musculoskeletal and Skin Diseases and others; BRAIST ClinicalTrials.gov number, 
NCT00448448.)
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Adolescent idiopathic scoliosis is characterized by a lateral curvature of the spine with a Cobb angle of more than 10 
degrees and vertebral rotation. Whereas scoliosis 
develops in approximately 3% of children younger 
than 16 years of age, only 0.3 to 0.5% have pro-
gressive curves requiring treatment.1 Curves larg-
er than 50 degrees are associated with a high risk 
of continued worsening throughout adulthood and 
thus usually indicate the need for surgery.2 In the 
United States in 2009, there were more than 3600 
hospital discharges for spinal surgery to correct 
adolescent idiopathic scoliosis, the total costs of 
which (approximately $514 million) ranked sec-
ond only to appendicitis among children 10 to 17 
years of age.3
Treatment with rigid bracing (thoracolumbo-
sacral orthosis) is the most common nonoperative 
treatment for the prevention of curve progression. 
There are many different brace designs, but with 
all of them, the objective is to restore the normal 
contours and alignment of the spine by means 
of external forces and, in some designs, the stimu-
lation of active correction as the patient moves 
the spine away from pressures within the brace.
Studies of bracing in adolescent idiopathic sco-
liosis have suggested that bracing decreases the 
risk of curve progression.4-10 However, the results 
were inconsistent, the studies were observation-
al, and only one prospective study enrolled both 
patients who underwent bracing and those who 
did not.11,12 Thus, the effect of bracing on curve 
progression and rate of surgery has remained un-
clear. We conducted the Bracing in Adolescent 
Idiopathic Scoliosis Trial (BRAIST) to determine 
the effectiveness of bracing, as compared with 
observation, in preventing progression of the curve 




We conducted BRAIST in 25 institutions across the 
United States and Canada. Enrollment began in 
March 2007. Initially, the trial was designed solely 
as a randomized trial. However, enrollment was 
slower than anticipated, because centers screened 
fewer eligible patients than anticipated and fewer 
families accepted randomization than the expect-
ed frequency of 25% of those approached. Since 
the main reason for declining randomization was 
a stated preference for one treatment over the 
other, a preference group was added to the trial 
in November 2009, which allowed patients to par-
ticipate by choosing their own treatment. There-
fore, the final design included both a randomized 
cohort and a preference cohort, with identical in-
clusion criteria, protocols, and outcomes assess-
ments (Fig. S1 in the Supplementary Appendix, 
available with the full text of this article at 
NEJM.org). Enrollment was completed in Febru-
ary 2011.
The study was approved by the human subjects 
committee at each institution and was overseen 
by an independent data and safety monitoring 
board appointed by the National Institute of Ar-
thritis and Musculoskeletal and Skin Diseases. 
The first and second authors take full responsi-
bility for the completeness and integrity of the 
data reported and for the adherence of the study 
to the protocol, available at NEJM.org. Additional 
information about the study initiation and prog-
ress is available elsewhere.13 The statistical 
analysis plan is available with the protocol.
PATIENT POPULATION
The target population for this study was patients 
with high-risk adolescent idiopathic scoliosis who 
met current indications for brace treatment: an 
age of 10 to 15 years, skeletal immaturity (defined 
as a Risser grade [a measure of the amount of 
ossification and eventual fusion of the iliac 
apophysis, on a scale of 0 to 5, with higher grades 
indicating greater skeletal maturity] of 0, 1, or 
214), and a Cobb angle for the largest curve of 20 
to 40 degrees.15 To be eligible, patients could not 
have received previous treatment for adolescent id-
iopathic scoliosis (Table S2 in the Supplementary 
Appendix). Eligibility was determined by the lo-
cal investigators. Standard information about the 
trial was presented to eligible patients by means 
of an online education module.
Patients who declined participation in the study 
were registered as screened, and their age, sex, 
race and ethnic group, curve type,16 Cobb angle 
of the largest curve, and reason for declining were 
recorded in a Web-based enrollment system. Pa-
tients providing assent to randomization received 
a computer-generated assignment to bracing or 
observation, which was stratified according to 
curve type (single thoracic curve vs. all other 
curves); patients in the preference cohort chose 
bracing or observation. Written informed consent 
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from the parent or guardian was required before 
any study procedures were initiated.
STUDY INTERVENTIONS
Patients in the observation group received no spe-
cific treatment. Patients in the bracing group re-
ceived a rigid thoracolumbosacral orthosis, pre-
scribed to be worn for a minimum of 18 hours per 
day. Participating centers prescribed the type of 
brace used in their normal clinical practice. Wear 
time was determined by means of a temperature 
logger (StowAway or TidbiT data logger, Onset 
Computer) embedded in the brace and pro-
grammed to log the date, time, and temperature 
every 15 minutes. A temperature of 28.0°C (82.4°F) 
or higher17,18 indicated that the brace was being 
worn. Patients who received a brace were consid-
ered to be treated, regardless of their level of com-
pliance with prescribed brace wear.
Both patients and clinicians were aware of the 
assigned treatment. However, all radiographic 
evaluations and outcome determinations were 
made at the central coordinating center by two 
readers (a research associate and a musculoskeletal 
radiologist) who were unaware of the treatment 
assignment and the treatment received.
DATA-COLLECTION AND FOLLOW-UP PERIODS
We collected radiographic, clinical, orthotic, and 
self-reported data at 6-month intervals. Adverse 
events and quality-of-life scores were monitored 
at each follow-up assessment and reported to the 
data and safety monitoring board. A complete list 
of these data is provided in Table S3 in the Sup-
plementary Appendix. The type of brace (Boston, 
Wilmington, or one of several other designs), 
specific customizations, and modifications over 
time were recorded. Temperature-monitor data 
were downloaded every 6 months by the research 
coordinator.
OUTCOMES
The primary outcome was determined when the 
first of two conditions was met: curve progression 
to 50 degrees or more (treatment failure) or skel-
etal maturity without this degree of curve pro-
gression (treatment success). The original matu-
rity outcome was based on the change in vertical 
height, with adjustment for the change in the 
Cobb angle.19 Owing to concerns regarding the 
accuracy and reliability of this measure, maturity 
was redefined as a Risser grade of 4 for girls (75 to 
100% ossification of the iliac apophysis, corre-
sponding to near-cessation of growth) or 5 for 
boys (100% ossification of the apophysis with fu-
sion to the ilium) and a Sanders digital maturity 
stage of 7 (defined as closure of all physes of the 
phalanges).20 This change was made before any 
analysis of the data. In the case of disagreement 
between the two primary readers regarding the 
treatment outcome, a third reader who was un-
aware of the treatment assignment and the 
treatment received broke the tie.
The score on the Pediatric Quality of Life In-
ventory (PedsQL), a generic quality-of-life instru-
ment used in studies of acute and chronic illness, 
was a secondary outcome.21,22 PedsQL scores 
range from 0 to 100, with higher scores indicating 
a better quality of life. Other secondary outcomes 
(not reported here) included health and function-
ing,23 self-image,24 and perception of spinal ap-
pearance.25
STATISTICAL ANALYSIS
The initial sample-size calculations assumed ran-
domization and an equal number of patients in 
each study group. The treatment-failure rate for 
bracing was set at 15% on the basis of the litera-
ture and the consensus of the protocol-develop-
ment committee. A survey of potential study par-
ticipants indicated that at least a 50% reduction 
in the risk of curvature progression warranting 
surgery would be required for patients to choose 
bracing,26 so the treatment-failure rate in the ob-
servation group was set at 30%. With an alpha level 
set at 0.05, a power of 90%, and allowance for a 
10% loss to follow-up, we calculated that a sam-
ple of 384 patients was required.
The statistical analysis plan prespecified a pri-
mary analysis that included data from the com-
bined randomized and preference cohorts accord-
ing to the treatment received and a secondary 
intention-to-treat analysis that included data only 
from the randomized cohort. In both analyses, 
we used logistic regression to estimate the odds 
ratio for successful treatment (indicated by skel-
etal maturity with a Cobb angle of <50 degrees) 
in the bracing group, as compared with the ob-
servation group.
In the primary analysis, we used propensity-
score adjustment to control for potential selection 
bias due to nonrandom treatment assignment in 
the preference cohort.27 The propensity-score–
derivation model was constructed with the use 
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of multivariable logistic regression, with bracing 
as the dependent variable. We made an a priori 
decision to include the baseline age and the Cobb 
angle of the largest curve, along with a variable 
indicating whether the patient had undergone ran-
domization. Additional variables, with no missing 
values, that were unbalanced between the study 
groups at a significance level of 0.05 were also 
considered for inclusion. The treatment effect was 
defined as the odds of success as a function of the 
treatment received, with adjustment for the dura-
tion of follow-up and quintiles of the propensity 
score.
Prespecified interim analyses were performed 
as requested by the data and safety monitoring 
board. The cumulative type I error rate was main-
383 Consented to participate
155 Were in randomized cohort
228 Were in preference cohort
1086 Patients were eligible for participation
703 Declined to participate
216 Opposed randomization
189 Opposed observation
120 Opposed to research or protocol
108 Opposed bracing
36 Preferred other type of brace
13 Found location of center inconvenient
21 Had other reasons
242 Were included in the primary analysis
141 Were not included in the primary analysis
(39 in the randomized cohort and 102
in the preference cohort)
1 Reached end point before initial visit
15 Withdrew
3 Were lost to follow-up
3 Had wrong diagnosis
119 Did not reach end point at time study
was stopped
116 Underwent randomization
and were included in
intention-to-treat population
126 Chose treatment
51 Were assigned to bracing
49 Underwent bracing
2 Underwent observation









Figure 1. Study Enrollment and Treatment of the Patients.
Between March 2007 and February 2011, a total of 1086 patients underwent screening. Of the 242 patients included in the primary anal-
ysis, 116 patients underwent randomization and were included in the intention-to-treat population. A total of 126 patients declined ran-
domization and chose their preferred treatment. Patients were permitted to change treatment groups on request.
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Table 1. Demographic and Clinical Characteristics at Baseline in the Primary-Analysis Population.*











Age — yr 12.7±1.1 12.6±1.1 12.7±1.2 12.7±1.0
Female sex — no. (%) 101 (87) 120 (95) 86 (90) 135 (92)
Race — no. (%)†
Black 15 (13) 7 (6) 11 (11) 11 (8)
White 88 (76) 101 (80) 73 (76) 116 (79)
Other 9 (8) 8 (6) 9 (9) 8 (5)
Unknown or not reported 4 (3) 10 (8) 3 (3) 11 (8)
Standing height — cm  154.4±11.6 156.2±7.7 153.6±10.6 156.5±9.1
SRS curve classification — no. (%)
Thoracic 25 (22) 34 (27) 21 (22) 38 (26)
Thoracolumbar 17 (15) 15 (12) 13 (14) 19 (13)
Lumbar 3 (3) 6 (5) 4 (4) 5 (3)
Double major 38 (33) 31 (25) 32 (33) 37 (25)
Double thoracic 6 (5) 16 (13) 7 (7) 15 (10)
Thoracic and thoracolumbar 20 (17) 13 (10) 13 (14) 20 (14)
Triple 7 (6) 11 (9) 6 (6) 12 (8)
Cobb angle of the largest curve — degrees‡ 30.5±6.0 30.3±6.1 30.3±6.5 30.5±5.8
Risser grade — no./total no. (%)‡§
0 70/115 (61) 72/125 (58) 60/94 (64) 82/146 (56)
1 25/115 (22) 39/125 (31) 19/94 (20) 45/146 (31)
2 17/115 (15) 10/125 (8) 12/94 (13) 15/146 (10)
3 2/115 (2) 3/125 (2) 3/94 (3) 2/146 (1)
4 1/115 (1) 0/125 0/94 1/146 (1)
5 0/115 1/125 (1) 0/94 1/146 (1)
Coronal balance — cm¶ 1.6±1.06 1.4±1.06 1.4±1.0 1.6±1.1
Sagittal balance — cm‖ 3.1±2.8 3.0±2.1 3.2±2.6 3.0±2.0
Kyphosis — degrees 34.8±11.9 33.3±12.7 34.6±12.4 33.6±12.3
Lordosis — degrees 59.9±12.3 60.2±12.1 60.1±12.4 59.8±12.1
PedsQL score** 82.2±14.1 84.9±13.4 83.3±13.3 83.8±14.1
*  Plus–minus values are means ±SD. There were no significant between-group differences at baseline, except for the comparisons of sex in 
the two study cohorts (P = 0.02) and standing height in the as-treated groups (P = 0.03). Data were missing for the following characteris-
tics: Risser grade (for 1 patient in the randomized cohort, 1 in the preference cohort, and 2 in the observation group), coronal balance (for 
5 patients in the randomized cohort, 8 patients in the preference cohort, 2 in the observation group, and 11 in the bracing group), sagittal 
balance (for 10 in the randomized cohort, 21 in the preference cohort, 12 in the observation group, and 19 in the bracing group), kyphosis 
(for 6 in the randomized cohort, 7 in the preference cohort, 4 in the observation group, and 9 in the bracing group), lordosis (for 6 in the 
randomized cohort, 7 in the preference cohort, 5 in the observation group, and 8 in the bracing group), and Pediatric Quality of Life Inventory 
(PedsQL) score (for 6 in the preference cohort, 2 in the observation group, and 4 in the bracing group). SRS denotes Scoliosis Research 
Society.
†  Race was self-reported. The “other” category included American Indian, Alaskan Native or First Nations, Asian, and Native Hawaiian or 
Pacific Islander.
‡  Radiographic measurements were from the centralized reading center. The readers identified 21 patients with radiographic measurements 
that did not meet the eligibility criteria (1 patient is included in more than one group listed here): a Cobb angle of less than 20 degrees in  
3 patients (1 in the randomized cohort, 2 in the preference cohort, 1 in the observation group, and 2 in the bracing group), a Cobb angle of 
more than 40 degrees in 10 (7 in the randomized cohort, 3 in the preference cohort, 6 in the observation group, and 4 in the bracing group), 
a Risser grade of 3 or more in 7 (3 in the randomized cohort, 4 in the preference cohort, 3 in the observation group, and 4 in the bracing 
group), and an unclassifiable Risser grade in 2 (1 in the randomized cohort, 1 in the preference cohort, and 2 in the observation group).
§  The Risser grade is a measure of the amount of ossification and eventual fusion of the iliac apophysis reflecting skeletal maturity.14 Grades 
range from 0 to 5, with higher grades indicating greater maturity.
¶  Coronal balance measures the offset of the top of the spine relative to the sacrum in the coronal plane.
‖  Sagittal balance measures the offset of the top of the spine relative to the sacrum in the sagittal plane.
** Scores on the PedsQL range from 0 to 100, with higher scores indicating better quality of life.
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tained at the planned level of 0.05 by means of 
the Lan–DeMets28 spending-function approach 
with the O’Brien–Fleming29 spending function. 
In addition to the effectiveness analysis, the data 
and safety monitoring board requested periodic 
evaluation of the patients’ first 6 months of tem-
perature-monitor data to assess whether patients 
were complying with the treatment at a level that 
would allow us to observe a treatment effect if, 
in fact, one existed. The average time (in hours) 
of brace wear per day was calculated and divided 
into quartiles. The chi-square test was used to 
assess the association between wear time and the 
rate of success.
R ESULT S
EARLY TERMINATION OF THE EFFECTIVENESS STUDY
The first interim analysis (September 2012) in-
cluded 178 patients, and the second (January 2013) 
included 230 patients. The prespecified P value 
for stopping the study because of efficacy was 
0.00821. The primary analysis yielded an adjusted 
odds ratio of 2.03 (95% confidence interval [CI], 
1.12 to 3.68; P = 0.0197), indicating a treatment 
benefit in favor of bracing. The data and safety 
monitoring board recommended termination of 
the trial not only on the basis of this analysis 
(with the P value close to the prespecified level 
for study termination) but also on the basis of 
the results of the intention-to-treat analysis and 
the observation of a strong positive association 
between the amount of time spent wearing the 
brace and the rate of success. The data and safety 
monitoring board instructed the study team to 
perform a data lock on all outcomes up to and 
including the date of the board meeting. The analy-
ses presented in this article were performed with 
the use of the resulting data set.
CHARACTERISTICS OF THE PATIENTS
Of 1183 patients screened, 1086 met the inclusion 
criteria and made a decision concerning study par-
ticipation (Fig. 1). A total of 383 patients (35%) 
provided assent, with written informed consent 
provided by a parent or guardian. These patients 
then either underwent randomization (155 pa-
tients [40%]) or declined randomization and in-
stead chose their treatment (228 [60%]). The 383 
patients with informed consent and the 703 who 
declined participation were similar with respect 
to age and sex distribution, but in the group with 
informed consent there was a slightly higher per-
centage of blacks and a slightly lower percentage 
of patients with a single lumbar curve or both a 
thoracic and a thoracolumbar curve (Table S4 in 
the Supplementary Appendix).
PRIMARY ANALYSIS
A total of 242 patients were included in the pri-
mary analysis: 116 patients (48%) in the random-
ized cohort and 126 (52%) in the preference cohort 
(Table 1). The two cohorts differed significantly 
at baseline with respect to sex distribution, the in-
terval between the diagnosis of scoliosis and trial 
enrollment, the person who first noticed the sco-
liosis, and the largest degree of apical vertebral ro-
tation (Table S5 in the Supplementary Appendix).
A total of 146 patients (60%) received a brace, 
and 96 (40%) underwent observation only. The 
two study groups were generally similar with re-
spect to baseline characteristics, except that the 
patients in the bracing group were taller on aver-
age than those in the observation group (156.5 cm 
vs. 153.6 cm, P = 0.03). The propensity-score model 
included baseline height, Cobb angle of the larg-
est curve, age, and status with respect to ran-
domization. The average duration of follow-up was 
21.3 months in the observation group and 24.2 
months in the bracing group (P = 0.01).
The rate of treatment success was 72% in the 
bracing group and 48% in the observation group 
(Table 2). With adjustment for the propensity-score 
quintile and duration of follow-up, the odds ratio 
for a successful outcome associated with bracing 
was 1.93 (95% CI, 1.08 to 3.46). Additional details 
of the propensity-score modeling are provided in 
the Supplementary Appendix.
INTENTION-TO-TREAT ANALYSIS
A total of 51 patients (44%) in the randomized 
cohort were assigned to bracing. There were no 






Primary analysis 46/96 (48) 105/146 (72) 1.93 (1.08–3.46)†
Intention-to-treat analysis 27/65 (42) 38/51 (75) 4.11 (1.85–9.16)
* Successful outcome was defined as skeletal maturity without curve progression 
to 50 degrees or more. The primary analysis included data from patients in the 
as-treated groups. The intention-to-treat analysis included data only from patients 
who had undergone randomization.
† The analysis was adjusted for propensity-score quintile and duration of follow-up.
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significant differences at baseline between the 
bracing and observation groups, except for the 
degree of lordosis (P = 0.02) (Table 3, and Table 
S6 in the Supplementary Appendix).
The rate of treatment success was 75% among 
patients randomly assigned to bracing, as com-
pared with 42% among those randomly assigned 
to observation (unadjusted odds ratio for success-
ful outcome with bracing, 4.11; 95% CI, 1.85 to 
9.16) (Table 2). The number needed to treat in 
order to prevent one case of curve progression 
warranting surgery was 3.0 (95% CI, 2.0 to 6.2), 
and the reduction in relative risk with bracing 
was 56% (95% CI, 26 to 82).
BRACE DOSE–RESPONSE RELATIONSHIP
The majority of patients assigned to bracing (68%) 
were treated with a customized Boston-type thora-
columbosacral orthosis. Temperature data were 
available for 116 patients (from both the random-
ized and preference cohorts). During the first 
6 months, patients wore the brace for a mean (±SD) 
of 12.1±6.5 hours per day (range, 0 to 23.0). The 
quartile of duration of brace wear was positively 
associated with the rate of success (P<0.001). The 
lowest quartile of wear (mean hours per day, 0 to 
6.0) was associated with a success rate (41%) sim-
ilar to that in the observation group in the pri-
mary analysis (48%), whereas brace wear for an 
average of at least 12.9 hours per day was associ-
ated with success rates of 90 to 93% (Fig. 2).
QUALITY OF LIFE AND ADVERSE EVENTS
The average PedsQL scores22 for patients included 
in the primary and intention-to-treat analyses did 
not differ significantly between the bracing and 
observation groups at baseline (Tables 1 and 3) 
or at the final follow-up assessment (mean scores 
in the primary analysis, 82.0 and 81.9, respec-
tively; P = 0.97; mean scores in the intention-to-
treat analysis, 79.1 and 81.2, respectively; P = 0.45) 
(Tables S7 and S8 in the Supplementary Appendix). 
There were no significant differences between the 
bracing and observation groups in the primary 
analysis with respect to the percentage of pa-
tients with any adverse event (P = 0.32) or the per-
centage of patients reporting back pain, the most 
common adverse event (P = 0.29). There was one 
serious adverse event, a hospitalization for anxi-
ety and depression in a patient who wore a brace. 
Adverse events involving the skin under the brace 
Table 3. Demographic and Clinical Characteristics at Baseline 






Age — yr 12.7±1.2 12.6±1.1
Female sex — no. (%) 56 (86) 45 (88)
Race — no. (%)
Black 11 (17) 4 (8)
White 47 (72) 41 (80)
Other 5 (8) 4 (8)
Unknown or not reported 2 (3) 2 (4)
Standing height — cm 153.8±12.0 155.3±11.1
SRS curve classification — no. (%)
Thoracic 15 (23) 10 (20)
Thoracolumbar 7 (11) 10 (20)
Lumbar 2 (3) 1 (2)
Double major 24 (37) 14 (27)
Double thoracic 4 (6) 2 (4)
Thoracic and thoracolumbar 10 (15) 10 (20)
Triple 3 (5) 4 (8)
Cobb angle of the largest curve —  
degrees†
31.3±6.7 29.4±4.7
Risser grade — no./total no. (%)†
0 41/64 (64) 29/51 (57)
1 14/64 (22) 11/51 (22)
2  7/64 (11) 10/51 (20)
3  2/64 (3)  0/51
4  0/64  1/51 (2)
Coronal balance — cm 1.6±1.0 1.7±1.1
Sagittal balance — cm 3.3±2.6 2.9±2.1
Kyphosis — degrees 34.3±11.7 35.2±12.5
Lordosis — degrees 57.3±12.9 62.8±10.8
PedsQL score 83.0±13.2 81.2±15.2
* There were no significant between-group differences at baseline, except for 
the degree of lordosis (P = 0.02). Data were missing for the following charac-
teristics: Risser grade (for one patient in the observation group), coronal bal-
ance (for two patients in the observation group and three in the bracing group), 
sagittal balance (for five in the observation group and five in the bracing group), 
kyphosis (for two in the observation group and four in the bracing group), 
and lordosis (for three in the observation group and three in the bracing 
group).
† Radiographic measurements were from the centralized reading center. The 
readers identified 12 patients with radiographic measurements that did not 
meet the eligibility criteria: a Cobb angle of less than 20 degrees in 1 patient 
in the observation group, a Cobb angle of more than 40 degrees in 7 in the 
observation group, a Risser grade of 3 or more in 3 (2 patients in the observa-
tion group and 1 in the bracing group), and an unclassifiable Risser grade in  
1 in the observation group.
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were reported in 12 of the 146 patients (8%) who 
wore a brace.
DISCUSSION
In adolescents with idiopathic scoliosis who were 
considered to be at high risk for curve progres-
sion that would eventually warrant surgery, brac-
ing was associated with a significantly greater like-
lihood of reaching skeletal maturity with a curve 
of less than 50 degrees, as compared with obser-
vation alone. A significant benefit of bracing was 
observed in both the randomized and the as-
treated populations. We also found a significant 
association between the average hours of daily 
brace wear and the likelihood of a successful out-
come. These findings corroborate those of previ-
ous prospective observational studies, which have 
shown a significantly lower rate of surgery among 
patients who wore a brace than among those who 
were untreated12 and a strong brace dose–response 
relationship.30
The rates of treatment failure in both groups 
in the randomized cohort were higher than ex-
pected, at 25% with bracing and 58% with ob-
servation; we hypothesized that the rates would 
be 15% and 30%, respectively. In previous stud-
ies, the rates of progression warranting surgery 
have varied widely, ranging from 0 to 79% after 
bracing 4,12,31 and from 10 to 38% in untreated pa-
tients.12,32-34 This variation could be due to dif-
ferences in case mix, inconsistent indications for 
surgery, differences in the quality of the brace 
and in patient compliance with brace wear, and 
nonblinded outcome evaluation.
Strengths of this study include the objective 
monitoring of the time spent wearing the brace; 
blinded, independent determination of the out-
come; the diversity of participating sites; and the 
a priori determination of the magnitude of risk 
reduction that was considered necessary by pa-
tients in order for them to choose bracing. The 
independent, blinded documentation of the out-
come of a large group of untreated patients can 
serve as a benchmark in future studies of treat-
ment for this condition.
BRAIST began as a randomized trial, but we 
were aware at the inception of the study that the 
majority of families would decline participation 
in order to pursue their own treatment prefer-
ences.26 Therefore, the relatively low enrollment 
rate and the need to include the preference co-
hort were not unexpected but resulted in a pri-
mary analysis that was an as-treated assessment 
rather than an intention-to-treat assessment. Po-
tential bias due to nonrandom treatment assign-
ment in this analysis is expected to be minimized, 
but is not eliminated, by the use of propensity-
score adjustment. In addition, the brace dose–
response analysis may be confounded by factors 
such as curve type, curve flexibility, and charac-
teristics of the brace. The observation that the 
intention-to-treat analysis yielded results that were 
similar to those of the as-treated analysis provides 
strong support for the conclusion that bracing re-
duces the risk of curve progression and the need 
for surgery.
Our findings have direct clinical applicability 
because they are derived from assessment of a 
group of patients for whom bracing would have 
been recommended in a typical orthopedic prac-
tice but in the absence of rigorous supporting 
data. It is also relevant that, in the primary analy-
sis, 48% of the patients in the observation group 
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Figure 2. Rate of Treatment Success According to Average Hours of Daily 
Brace Wear.
During the first 6 months, patients wore the brace for a mean (±SD) of 
12.1±6.6 hours per day (range, 0 to 23.0). Duration of brace wear was posi-
tively associated with the rate of success (P<0.001 by the chi-square test). 
The lowest quartile of wear (mean hours per day, 0 to 6.0) was associated 
with a success rate of 42%, whereas brace wear for an average of at least 
12.9 hours per day was associated with success rates of 90 to 93%. I bars 
indicate 95% confidence intervals. 
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tients in the bracing group who spent little time 
actually wearing the brace. As others have sug-
gested,12,35 current bracing indications may be too 
broad, resulting in unnecessary treatment for 
many patients. It is important to identify patients 
at high risk for clinically significant curve progres-
sion who are also most likely to benefit from 
bracing.
In conclusion, bracing significantly decreased 
the progression of high-risk curves to the thresh-
old for surgery in patients with adolescent idio-
pathic scoliosis. Longer hours of brace wear were 
associated with greater benefit.
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